A Randomized, Double-Blind Trial to Test Higher- Versus Lower-Doses of Aspirin on Inflammatory Markers and Platelet Biomarkers and Nitric Oxide Formation Endothelial Function in Secondary Prevention (Pts w/Chronic Stable Coronary Disease).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Aspirin (Primary)
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Biomarker; Pharmacodynamics
- Acronyms TAD
- 28 Dec 2018 Biomarkers information updated
- 22 Jun 2012 Actual patient number changed from 70 to 37 as reported by ClinicalTrials.gov.
- 15 Jun 2012 Actual end date changed from Jan 2009 to Jun 2009 as reported by ClinicalTrials.gov.